Yifu Li

机构：Central South University, Harbin Medical University, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Harbin Medical University · ORCID：0000-0002-7077-7689

发表论文 88 篇 · 总被引 5736 次 · h-index 32

代表论文

• Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial (2024 · The Lancet Oncology · 被引 70)
• NEMF-mediated Listerin-independent mitochondrial translational surveillance by E3 ligase Pirh2 and mitochondrial protease ClpXP (2024 · Cell Reports · 被引 18)
• Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy (2025 · Journal of Clinical Investigation · 被引 15)
• Operational characteristics in varied gradients of low carbon-to-nitrogen ratios utilizing a novel integrated bacteria-algae synergistic biofilm reactor for wastewater treatment (2024 · Journal of Water Process Engineering · 被引 11)
• Enhanced aerobic granular sludge by thermally-treated dredged sediment in wastewater treatment under low superficial gas velocity (2024 · Journal of Environmental Management · 被引 10)
• Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma (2025 · JAMA Oncology · 被引 9)